GHP Investment Advisors Inc. decreased its stake in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 0.8% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 81,684 shares of the technology company’s stock after selling 686 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Plexus were worth $11,053,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of PLXS. TD Private Client Wealth LLC boosted its holdings in shares of Plexus by 185.6% during the 1st quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company’s stock worth $66,000 after buying an additional 334 shares during the period. Banque Transatlantique SA acquired a new position in shares of Plexus in the first quarter valued at approximately $71,000. CWM LLC grew its position in shares of Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after purchasing an additional 213 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new position in shares of Plexus in the first quarter valued at approximately $87,000. Finally, Meeder Asset Management Inc. acquired a new position in shares of Plexus in the first quarter valued at approximately $121,000. Institutional investors own 94.45% of the company’s stock.
Plexus Trading Down 0.8%
Shares of PLXS stock opened at $139.90 on Friday. The company has a current ratio of 1.58, a quick ratio of 0.77 and a debt-to-equity ratio of 0.06. The stock has a market cap of $3.78 billion, a P/E ratio of 22.35 and a beta of 0.80. The stock has a 50 day simple moving average of $142.02 and a 200 day simple moving average of $134.78. Plexus Corp. has a 1 year low of $103.43 and a 1 year high of $172.89.
Insider Activity at Plexus
In other news, insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $139.00, for a total transaction of $417,000.00. Following the completion of the sale, the insider owned 8,723 shares of the company’s stock, valued at approximately $1,212,497. This represents a 25.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 1,998 shares of the company’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $142.80, for a total value of $285,314.40. Following the sale, the chief financial officer owned 18,961 shares of the company’s stock, valued at $2,707,630.80. The trade was a 9.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,354 shares of company stock worth $2,239,309 in the last 90 days. Corporate insiders own 1.76% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. Stifel Nicolaus set a $150.00 target price on Plexus in a research report on Friday, October 24th. Needham & Company LLC upped their target price on Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Sidoti downgraded Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a research report on Friday, October 24th. Wall Street Zen downgraded Plexus from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 19th. Finally, Benchmark reaffirmed a “buy” rating and issued a $165.00 target price on shares of Plexus in a research report on Friday, October 24th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $159.00.
View Our Latest Stock Report on PLXS
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles
- Five stocks we like better than Plexus
- What is the S&P 500 and How It is Distinct from Other Indexes
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Low PE Growth Stocks: Unlocking Investment Opportunities
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- 3 Warren Buffett Stocks to Buy Now
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
